UPDATE 1-Eli Lilly insulin drug receives tentative U.S. approval

August 19, 2014 1:13 AM

5 0

Aug 18 (Reuters) - The U.S. Food and Drug Administration granted tentative approval for Eli Lilly and Co and Boehringer Ingelheim's insulin injection that helps control blood sugar levels in diabetes patients, Lilly said in a statement.

The drug, Basaglar, is intended to provide long-lasting blood sugar control in between meals and during the night. It is approved for adults with type 2 diabetes and in combination with mealtime insulin in adults and children with type 1 diabetes.

Also read: Israeli court sentences tycoon to 2 years in prison

Read more

To category page

Loading...